Shirley
Shirley Alansky, Rockledge, FL US
Patent application number | Description | Published |
---|---|---|
20150195687 | PUSH TO TALK VIRTUAL KEY - According to at least one exemplary embodiment, a Push-To-Talk virtual key may be disclosed. The virtual key may include a hardware adapter for connecting a headset, handset, or other PTT device to a computer. The virtual key may also include software that causes the PTT device to act as an input key on the computer keyboard, mouse, or other input device. | 07-09-2015 |
Shirley Bortfeldt-Herkendell, Berlin DE
Patent application number | Description | Published |
---|---|---|
20090207004 | Method for the Protection of a Movable Object, Especially a Vehicle, Against Unauthorized Use - The invention relates to a method for protection of a movable asset, particularly a motorvehicle ( | 08-20-2009 |
Shirley Chan, Dunn Loring, VA US
Patent application number | Description | Published |
---|---|---|
20150286946 | SYSTEMS AND METHODS FOR AN ATTRIBUTE GENERATOR TOOL WORKFLOW - The disclosed embodiments generally relate to systems and methods for computerized decisioning, and more particularly, to systems and methods for standardized coding and deployment of attributes for financial decisioning systems coded once and deployed to multiple decisioning systems and environments. Consistent with disclosed embodiments, an attribute management system may include one or more memory devices storing instructions, and one or more hardware processors configured to execute the instructions to perform operations. Upon executing the instructions, the processors may receive a financial service request, and identify a decisioning system for processing the request. The processors may determine that an attribute is required for processing the request using the decisioning system. Then, the processors may initiate an attribute calculation service for determining an attribute value for the attribute. The processors may receive the attribute value from the attribute calculation service, and process the financial service request using the received attribute value. | 10-08-2015 |
Shirley Collins, Spartanburg, SC US
Patent application number | Description | Published |
---|---|---|
20130264806 | Portable Power Device - A portable power device for powering an existing crankshaft operated semi trailer landing gear is disclosed. The portable power device comprises a motor for rotating a drive shaft with an engaging end. An opening in the drive shaft fits over the engaging end for mating with the existing crankshaft once a hand crank is removed. The portable power device further comprises a plurality of sockets for engaging a lug nut. | 10-10-2013 |
Shirley Foster, Kentfield, CA US
Patent application number | Description | Published |
---|---|---|
20130304620 | USING A VALUE-ASCERTAINABLE ITEM TO OBTAIN CREDIT AT A THIRD-PARTY MERCHANT - Techniques are provided for providing value to a user in exchange for the user's value-ascertainable item. In one technique, the user, while in a merchant's store, uses a mobile device to scan a QR code that triggers a browser application to send a request to an exchange service over a network. The request includes data that is associated with the merchant. The user provides card data of a particular gift card to the exchange service. The exchange service checks the balance of the card and sends an offer for the card to the user. If the user accepts, then the exchange service sends account information and/or a bar code to the user's mobile device. The account information or bar code can be used immediately by the user to purchase one or more items at the store. | 11-14-2013 |
Shirley Gil Parrado, Binningen CH
Patent application number | Description | Published |
---|---|---|
20080214548 | 2-Cyano-Pyrimidines and-Triazines as Cysteine Protease Inhibitors - The invention relates to compounds of the formula I | 09-04-2008 |
Shirley Grill, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20080208715 | METHOD, SYSTEM AND APPARATUS FOR PROVIDING A PERSONALIZED ELECTRONIC SHOPPING CENTER - According to embodiments of the present invention, a user's local storage system may be used to create a virtual personal mall comprising one or more virtual personal stores and configured for purchasing products by one or several providers. The virtual personal store and/or virtual personal mall may be organized in virtual shelves. Each virtual shelf may contain a group of products with one or more common properties, for example, books by a certain author and/or published by a certain publisher, and/or supplied by the same virtual personal store provider, etc. The groups may be defined by the virtual personal store provider and/or by the user and/or by a group of users. | 08-28-2008 |
Shirley Hoenigman, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20090230300 | RAPID DETECTION OF VOLATILE ORGANIC COMPOUNDS FOR IDENTIFICATION OF BACTERIA IN A SAMPLE - In various embodiments, the invention relates to a method for identifying the presence of particular bacteria in a sample. The method includes collecting a sample that includes or has been exposed to the particular bacteria and detecting, in the sample, at least one volatile organic compound indicative of the presence of the bacteria. | 09-17-2009 |
20090239252 | RAPID DETECTION OF VOLATILE ORGANIC COMPOUNDS FOR IDENTIFICATION OF BACTERIA IN A SAMPLE - In various embodiments, the invention relates to a method for identifying the presence of particular bacteria in a sample. The method includes collecting a sample that includes or has been exposed to the particular bacteria and detecting, in the sample, at least one volatile organic compound indicative of the presence of the bacteria. | 09-24-2009 |
Shirley Jones, Seacroft GB
Patent application number | Description | Published |
---|---|---|
20120034017 | ANTIPERSPIRANT COMPOSITIONS AND PRODUCTS - The perceived visual appearance of skin such as axilla skin, as indicated by tone, radiance and/or smoothness, is improved significantly by topical application of an antiperspirant composition that is a roll-on emulsion that comprises a dihydric or trihydric humectant and/or a glyceride oil. and a mica pigment, The visual appearance can be further enhanced by incorporating into the composition a particulate microfine aluminium oxide and/or a silicone elastomer. The mica-containing compositions are advantageously applied from a roll-ball dispenser in which the depth of film of fluid on the rolling ball is controlled, such as by a spider spaced inward of the ball and/or the flow of fluid within the ball housing is perturbed such as by a castellated sealing ring and/or a shallow bead outward of the sealing ring within the ball housing. | 02-09-2012 |
20120039833 | ANTIPERSPIRANT COMPOSITION COMPRISING MICA AND FATTY ALCOHOL WAX - The visual appearance of skin such as axilla skin is not improved significantly by topical application of an antiperspirant composition that is a stick that comprises at least 8% by weight of a fatty alcohol gellant. The visual appearance of a cosmetic antiperspirant composition comprising 5-30% of an astringent antiperspirant salt, 40-80% of a continuous liquid phase comprising at least one water-immiscible oil and 5-30% of a fatty alcohol wax gellant, as indicated by tone, radiance and smoothness, is enhanced by incorporating at least 0,25% of a mica pigment, optionally on the presence of a di or tri-hydric humectant and/or a triglyceride oil. Preferably the composition comprises 20 to 35% by weight of a non-volatile oil, and/or a co-gellant that melts at from 75 to 90° C. such as caster wax or polyethylene of molecular weight 300 to 600. | 02-16-2012 |
Shirley Larom, Zichron Ya'Akov IL
Patent application number | Description | Published |
---|---|---|
20110154541 | BIO-ENGINEERED PHOTOSYSTEMS - The present invention relates to bio-engineered photosystems, specifically photosystem II (PSII) having an alternative electron transfer pathway that enables electron flow from PSII to a water-soluble protein electron carrier. The present invention further relates to methods and systems for electron transfer using the bio-engineered photosystems. Such photosystems may be utilized for electrical energy production, hydrogen production and/or reduction of carbon-based gases (for example, CO | 06-23-2011 |
20140223610 | BIO-ENGINEERED PHOTOSYSTEMS - The present invention relates to bio-engineered photosystems, specifically photosystem II (PSII) having an alternative electron transfer pathway that enables electron flow from PSII to a water-soluble protein electron carrier. The present invention further relates to methods and systems for electron transfer using the bio-engineered photosystems. Such photosystems may be utilized for electrical energy production, hydrogen production and/or reduction of carbon-based gases (for example, CO | 08-07-2014 |
Shirley Lee, Poway, CA US
Patent application number | Description | Published |
---|---|---|
20080238992 | Printing device - Embodiments of a biodegradable absorbent material in a permeable membrane are disclosed. | 10-02-2008 |
Shirley Lima Campos, Belo Horizonte BR
Patent application number | Description | Published |
---|---|---|
20110160683 | DEVICE FOR CONTROLLING AND MONITORING VACUUM PRESSURE IN SYSTEMS FOR THE SUCTION OF BIOLOGICAL SECRETIONS - The present invention concerns a vacuum pressure control and monitoring device for aspiration of biological secretions from respiratory routes, as well as of other biological fluids. The proposed device consists of a vacuum pressure regulating valve integrated to a monitoring system, which can be coupled together a hospital vacuum network and portable aspiration apparatus in ambulatory and household environments. The said device is designed to control and monitor maximum vacuum aspiration pressures, in this way preventing injuries during aspiration procedures. | 06-30-2011 |
Shirley Lin, Taipei City TW
Patent application number | Description | Published |
---|---|---|
20100031087 | METHOD OF CONTROL IN A SYSTEM HAVING A MEDIA READER - A method of control in a system, which includes a media reader and a host unit, includes configuring the host unit to detect whether the media reader is responding, and configuring the host unit to reset the media reader when it is detected that the media reader stops responding. A system that includes the media reader and the host unit is also disclosed. | 02-04-2010 |
Shirley Lin, Chang Hua TW
Patent application number | Description | Published |
---|---|---|
20090188570 | Rapid inflation device - A rapid inflation device for connecting a forced air supply source to the air nozzle of a tire that has an air valve mounted therein for controlling input and output of air is disclosed to include a casing for connection to the air nozzle, an air intake connector rotatably mounted on the casing for the connection of the forced air supply source, and a valve pickup device for carrying the air valve away from the air nozzle to let forced air pass from the forced air supply source into the inside of the tire freely or to let tire air be discharged out of the tire through the same circulation path. By means of rotating the air intake connector forwards or backwards, the forced air supply source is connected to or disconnected from the rapid inflation device. | 07-30-2009 |
Shirley Longacre, Paris FR
Patent application number | Description | Published |
---|---|---|
20080286805 | Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use - Accordingly, the invention provides constructs in which the nucleic acids encoding | 11-20-2008 |
20100092520 | Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use - Accordingly, the invention provides constructs in which the nucleic acids encoding | 04-15-2010 |
20100255038 | PURIFIED POLYPEPTIDE COMPRISING OR CONSISTING OF A C-TERMINUS MSP1 ANTIGEN FROM PLASMODIUM FALCIPARUM CARRYING A GLYCOSYL-PHOSPHATIDYL-INOSITOL GROUP (GPI) - The present invention relates to a purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from | 10-07-2010 |
20120115156 | RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEINS 4 AND 5 AND THEIR USE - Accordingly, the invention provides constructs in which the nucleic acids encoding | 05-10-2012 |
20130129766 | RECOMBINANT PLASMODIUM FALCIPARUM MEROZOITE SURFACE PROTEINS 4 AND 5 AND THEIR USE - Accordingly, the invention provides constructs in which the nucleic acids encoding | 05-23-2013 |
Shirley Longacre-Andre, Paris FR
Patent application number | Description | Published |
---|---|---|
20100291133 | RECOMBINANT PROTEIN CONTAINING A C-TERMINAL FRAGMENT OF PLASMODIUM MSP-1 - The invention relates to a recombinant protein fabricated in a baculovirus system, of which the essential constitutive polypeptide sequence is that of a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (protein MSP-1) of the merozoite parasite of the | 11-18-2010 |
Shirley M. Carter Alston Waters, Glen Burnie, MD US
Patent application number | Description | Published |
---|---|---|
20110309218 | Lid Support Device - A lid support device and method for supporting a container lid for a container. The lid support device features a handle connected to a fan shaped lid rest. The lid rest comprises a clip. The clip extends through the container and the container lid to secure the device to the container lid and the container. The handle height is adjustable so that the handle and lid rest support the container lid when it is not covering the container. The device features a base that is the mirror image shape of the lid rest. | 12-22-2011 |
Shirley Mihardja, Daly City, CA US
Patent application number | Description | Published |
---|---|---|
20100291080 | COMPOSITIONS AND METHODS FOR TISSUE REPAIR - The present invention provides compositions and methods for targeting an extracellular matrix derived (EMD) peptide predominantly to an injured tissue, as opposed to an uninjured tissue in vivo. The targeted EMD peptide facilitates the repair and/or regeneration of the injured tissue by providing a surface for cells to attach and grow, thereby facilitating the repair and/or regeneration of the injured tissue. | 11-18-2010 |
20150104478 | COMPOSITIONS AND METHODS FOR TISSUE REPAIR - The present invention provides compositions and methods for targeting an extracellular matrix derived (EMD) peptide predominantly to an injured tissue, as opposed to an uninjured tissue in vivo. The targeted EMD peptide facilitates the repair and/or regeneration of the injured tissue by providing a surface for cells to attach and grow, thereby facilitating the repair and/or regeneration of the injured tissue. | 04-16-2015 |
Shirley Poduslo, North Augusta, SC US
Patent application number | Description | Published |
---|---|---|
20110135572 | COMPOSITIONS AND METHODS FOR DIAGNOSING LATE-ONSET ALZHEIMER'S DISEASE - Genetic markers for late-onset Alzheimer's disease (AD) within the TRPC4AP gene locus are provided. The genetic markers include single nucleotide polymorphisms (SNPs) and haplotypes. Methods and kits for using the disclosed genetic markers to identify, or assist in the identification of, subjects as having late-onset AD, or as having an increased risk for developing late-onset AD are provided. In a preferred embodiment the genetic markers are one or more SNPs selected from the group consisting of rs1058003, rs3746430, rs3736802, rs6088677, rs6087660, rs4911460, rs6087664, rs13042358, rs6088692, rs6120816, rs1885119, rs2065108 and rs6088727, or haplotype: rs1058003_G: rs3746430_T: rs3736802_T: rs6088677_C: rs6087660_T: rs4911460_G: rs6087664_C: rs13042358_G: rs6120816_G: rs1885119_T. | 06-09-2011 |
Shirley Sameach-Greenwald, Kfar-Saba IL
Patent application number | Description | Published |
---|---|---|
20110052501 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KIAA0746, CD20 or CD55 antigens, which are differentially expressed in cancer and in specific blood cells, and diagnostic and therapeutic usages. This invention further relates to the discovery of extracellular domains of KIAA0746 and its variants, CD20 and its variants, CD55 and its variants, which are suitable targets for immunotherapy, cancer therapy, treatment of inflammatory, allergic and autoimmune disorders, and drug development. | 03-03-2011 |
20110311450 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KRTCAP3, FAM26F, MGC52498, FAM70A or TMEM154 antigens, which are differentially expressed in cancer, and diagnostic and therapeutic usages. This invention further relates to extracellular domains of KRTCAP3, FAM26F, MGC52498, FAM70A and TMEM154 proteins and variants, and therapeutic usages thereof. | 12-22-2011 |
20120134997 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development. | 05-31-2012 |
20130315819 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against KIAA0746, CD20 or CD55 antigens, which are differentially expressed in cancer and in specific blood cells, and diagnostic and therapeutic usages. This invention further relates to the discovery of extracellular domains of KIAA0746 and its variants, CD20 and its variants, CD55 and its variants, which are suitable targets for immunotherapy, cancer therapy, treatment of inflammatory, allergic and autoimmune disorders, and drug development. | 11-28-2013 |
20140220011 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, ClORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and ClORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development. | 08-07-2014 |
20140255389 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants which are suitable targets for immunotherapy, cancer therapy, and drug development. | 09-11-2014 |
20140255411 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants a which are suitable targets for immunotherapy, cancer therapy, and drug development. | 09-11-2014 |
20140294765 | LSR ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER - This invention relates to antibodies and antigen binding fragments and conjugates containing same, and/or alternative scaffolds, specific for LSR molecules, which are suitable drugs for immunotherapy and treatment of specific cancer. | 10-02-2014 |
20140363446 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS - This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against VSIG1, ILDR1, LOC253012, AI216611, C1ORF32 or FXYD3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and therapeutic usages. The use of these antibodies for modulating B7 costimulation and related therapies such as the treatment of autoimmunity are also provided. This invention further relates to the discovery of extracellular domains of VSIG1 and its variants, FXYD3 and its variants, ILDR1 and its variants, LOC253012 and its variants, AI216611 and its variants, and C1ORF32 and its variants awhich are suitable targets for immunotherapy, cancer therapy, and drug development. | 12-11-2014 |
Shirley Samuel-Verghese, Kuala Lumpur MY
Patent application number | Description | Published |
---|---|---|
20090285859 | Allergenic proteins of natural rubber latex, their production and use in assays - This invention relates to allergenic proteins of natural rubber latex in substantially purified form, their production and their use, together with monoclonal antibodies developed against those allergenic proteins, in assays for the qualitative and quantitative determination of the levels of the allergenic proteins in natural rubber latex or in products made from latex. Assays for identifying and/or quantitating antibodies in blood or blood products that mediate the occurrence of an allergic reaction induced by natural rubber latex are also provided, together with in vivo and in vitro diagnostic tests for detecting hypersensitivity to natural rubber latex and which involve use of the aforesaid allergenic proteins. The invention also provides for the use of the aforesaid allergens as de-sensitising agents in the treatment of latex protein allergy. There is still further provided a method for removing allergenic proteins from latex products. | 11-19-2009 |
Shirley Smith, Fort Smith, AR US
Patent application number | Description | Published |
---|---|---|
20130007941 | Shower Jacket - The shower jacket is provided as a one-piece body garment that has a minimum number of parts, which includes a front portion, a vertically right side slit portion underneath the arm section, divided into two segments that will be fastened. It has a fully closed back portion, as well as an opening for arms and the neck. Fasteners are for retaining the two segments of the vertical right-side portion segments together at three sections along the side of the garment in three-button sections. This component is for securing and covering up the entire body of the patient in order to provide warmth, privacy, safety, and a sense of modesty and dignity. It also has a convenient front four-compartment pocket to aid in supplying a patient's necessity items for the bath or shower. It allows easy access for patients with medical equipment, and for examinations to the body. | 01-10-2013 |
20130305446 | Disposable Shower Bucket and The Privacy Jacket - The disposable shower bucket is provided as a component used to provide comfort and secure the dignity of patients in healthcare facilities. It is comprised of a soft, flexible, round molded texture that has a inner layer composed of padding sections to helps separate and absorb both feces and wastes as they are exposed of by the body. The disposable bucket is designed to be used with the Privacy Jacket (U.S. Patent No. 61/518,982) by attaching inside the back-inner portion of the garment. It can also be used with The Shower Jacket (U.S. Pat No. 61/518,983). It is to be used with a standardized shower chair, and can be worn by the patient as they are transported from location to location. It fits securely under the shower chair and aids in providing cleanliness, comfort and support, and dignity to all patients. | 11-21-2013 |
Shirley Steinberg-Shapira, Haifa IL
Patent application number | Description | Published |
---|---|---|
20150011842 | METHOD AND DEVICE FOR STUTTERING ALLEVIATION - A device for stuttering alleviation is disclosed, comprising a speech sensor, configured to output signals indicative of speech, a processing unit configured to detect stuttering, log stuttering and/or produce stimulation indication based on stimulation rules Said device may further comprise a remote server and a server user interface, configured to allow the speech therapist access to the processing unit. Further provided is a method for accelerating the learning procedure for obtaining a permanent fluent speech, comprising receiving and analyzing speech parameters, determining whether a negative reinforcement is required and executing the negative reinforcement. | 01-08-2015 |
Shirley Villadiego, Miami, FL US
Patent application number | Description | Published |
---|---|---|
20130004525 | INACTIVATING PATHOGENS WITH OXIDIZING AGENTS FOR VACCINE PRODUCTION - The present disclosure provides methods for producing a vaccine composition containing a pathogen that is rendered noninfectious by exposure to hydrogen peroxide. The methods disclosed herein are suitable for the preparation of vaccines for a wide variety of pathogens, including viruses, bacteria and parasites. The disclosure also provides vaccine compositions (medicaments) containing a pathogen inactivated by exposure to hydrogen peroxide. Methods for eliciting an immune response in a subject by administering vaccine compositions containing a hydrogen peroxide inactivated pathogen are also provided. | 01-03-2013 |
20140242115 | INACTIVATING PATHOGENS WITH OXIDIZING AGENTS FOR VACCINE PRODUCTION - The present disclosure provides methods for producing a vaccine composition containing a pathogen that is rendered noninfectious by exposure to hydrogen peroxide. The methods disclosed herein are suitable for the preparation of vaccines for a wide variety of pathogens, including viruses, bacteria and parasites. The disclosure also provides vaccine compositions (medicaments) containing a pathogen inactivated by exposure to hydrogen peroxide. Methods for eliciting an immune response in a subject by administering vaccine compositions containing a hydrogen peroxide inactivated pathogen are also provided. | 08-28-2014 |